2018年风湿病学领域华人学者又有哪些新发现?

2019-02-16 Joyce 合指数innovindex

2018年我国(含港澳台)作者在风湿病领域共发文4, 737篇(文章中至少有一位华人作者),位于第二位,仅次于美国(见图1)。 图1 2018年全球风湿病领域发文数量前10名的国家 根据论文被引频次、期刊影响因子(IF)、ESI高被引/热点文献等指标,合指数综合评选出了2018年风湿病领域最受关注的华人学者发表的论文前20名,并对前10名的主要研究成果进行了编译与总结,

2018年我国(含港澳台)作者在风湿病领域共发文4, 737篇(文章中至少有一位华人作者),位于第二位,仅次于美国(见图1)。

图1 2018年全球风湿病领域发文数量前10名的国家

根据论文被引频次、期刊影响因子(IF)、ESI高被引/热点文献等指标,合指数综合评选出了2018年风湿病领域最受关注的华人学者发表的论文前20名,并对前10名的主要研究成果进行了编译与总结,快来一起看看吧!

表1 2018年风湿病学领域华人学者发文TOP 20

从表1可以看出,2018年风湿病学领域华人学者发文TOP 20中,所发表期刊的平均影响因子为13.47,最高的为Science(IF:41.06),发表篇数最多的杂志为ANNALS OF THE RHEUMATIC DISEASES(6篇,IF: 12.35),占到总数的30%。

从地理分布上看,通讯作者所在机构以北京江苏居多(见图2),清华大学南京大学医学院附属南京鼓楼医院在入围篇数上领跑,各有3篇论文入选TOP 20榜单。入围篇数最多的学者为南京大学医学院附属南京鼓楼医院风湿免疫科孙凌云,有3篇文章入围。清华大学基础医学院董晨中国医药大学附设医院风湿免疫科陈得源(中国台湾)也各有两篇文章入围。

图2 通讯作者所在机构地理分布

从合作发文和独家发文的角度看,排名前20的论文全部采取的是国际、国内联合发表的形式,其中国际合作比例为65%,国内合作为35%。(见图3)

图3 论文发表合作情况

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1921238, encodeId=5a1419212386e, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Thu Nov 14 16:54:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582032, encodeId=f789158203275, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Mon Feb 18 13:54:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623030, encodeId=befe1623030ca, content=<a href='/topic/show?id=54a7358e4cb' target=_blank style='color:#2F92EE;'>#华人学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35874, encryptionId=54a7358e4cb, topicName=华人学者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1720449156, createdName=zhangxingru, createdTime=Mon Feb 18 13:54:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360853, encodeId=272e360853f0, content=真棒,继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sun Feb 17 12:53:44 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360845, encodeId=c64f3608454f, content=向各位专家学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtpPKU0wCQJX0qlicBd0iaQKZSwfxZJgU3Ep22UHmz5TRb7GYJePEmLTeibImwstiaEU5lqUQNCicibGkn/0, createdBy=bdcb1652180, createdName=lixon1988, createdTime=Sun Feb 17 11:18:36 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360829, encodeId=daef36082944, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Sun Feb 17 09:12:23 CST 2019, time=2019-02-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1921238, encodeId=5a1419212386e, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Thu Nov 14 16:54:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582032, encodeId=f789158203275, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Mon Feb 18 13:54:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623030, encodeId=befe1623030ca, content=<a href='/topic/show?id=54a7358e4cb' target=_blank style='color:#2F92EE;'>#华人学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35874, encryptionId=54a7358e4cb, topicName=华人学者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1720449156, createdName=zhangxingru, createdTime=Mon Feb 18 13:54:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360853, encodeId=272e360853f0, content=真棒,继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sun Feb 17 12:53:44 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360845, encodeId=c64f3608454f, content=向各位专家学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtpPKU0wCQJX0qlicBd0iaQKZSwfxZJgU3Ep22UHmz5TRb7GYJePEmLTeibImwstiaEU5lqUQNCicibGkn/0, createdBy=bdcb1652180, createdName=lixon1988, createdTime=Sun Feb 17 11:18:36 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360829, encodeId=daef36082944, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Sun Feb 17 09:12:23 CST 2019, time=2019-02-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1921238, encodeId=5a1419212386e, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Thu Nov 14 16:54:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582032, encodeId=f789158203275, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Mon Feb 18 13:54:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623030, encodeId=befe1623030ca, content=<a href='/topic/show?id=54a7358e4cb' target=_blank style='color:#2F92EE;'>#华人学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35874, encryptionId=54a7358e4cb, topicName=华人学者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1720449156, createdName=zhangxingru, createdTime=Mon Feb 18 13:54:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360853, encodeId=272e360853f0, content=真棒,继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sun Feb 17 12:53:44 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360845, encodeId=c64f3608454f, content=向各位专家学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtpPKU0wCQJX0qlicBd0iaQKZSwfxZJgU3Ep22UHmz5TRb7GYJePEmLTeibImwstiaEU5lqUQNCicibGkn/0, createdBy=bdcb1652180, createdName=lixon1988, createdTime=Sun Feb 17 11:18:36 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360829, encodeId=daef36082944, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Sun Feb 17 09:12:23 CST 2019, time=2019-02-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1921238, encodeId=5a1419212386e, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Thu Nov 14 16:54:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582032, encodeId=f789158203275, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Mon Feb 18 13:54:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623030, encodeId=befe1623030ca, content=<a href='/topic/show?id=54a7358e4cb' target=_blank style='color:#2F92EE;'>#华人学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35874, encryptionId=54a7358e4cb, topicName=华人学者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1720449156, createdName=zhangxingru, createdTime=Mon Feb 18 13:54:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360853, encodeId=272e360853f0, content=真棒,继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sun Feb 17 12:53:44 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360845, encodeId=c64f3608454f, content=向各位专家学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtpPKU0wCQJX0qlicBd0iaQKZSwfxZJgU3Ep22UHmz5TRb7GYJePEmLTeibImwstiaEU5lqUQNCicibGkn/0, createdBy=bdcb1652180, createdName=lixon1988, createdTime=Sun Feb 17 11:18:36 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360829, encodeId=daef36082944, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Sun Feb 17 09:12:23 CST 2019, time=2019-02-17, status=1, ipAttribution=)]
    2019-02-17 医者仁心5538

    真棒,继续努力

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1921238, encodeId=5a1419212386e, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Thu Nov 14 16:54:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582032, encodeId=f789158203275, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Mon Feb 18 13:54:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623030, encodeId=befe1623030ca, content=<a href='/topic/show?id=54a7358e4cb' target=_blank style='color:#2F92EE;'>#华人学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35874, encryptionId=54a7358e4cb, topicName=华人学者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1720449156, createdName=zhangxingru, createdTime=Mon Feb 18 13:54:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360853, encodeId=272e360853f0, content=真棒,继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sun Feb 17 12:53:44 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360845, encodeId=c64f3608454f, content=向各位专家学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtpPKU0wCQJX0qlicBd0iaQKZSwfxZJgU3Ep22UHmz5TRb7GYJePEmLTeibImwstiaEU5lqUQNCicibGkn/0, createdBy=bdcb1652180, createdName=lixon1988, createdTime=Sun Feb 17 11:18:36 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360829, encodeId=daef36082944, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Sun Feb 17 09:12:23 CST 2019, time=2019-02-17, status=1, ipAttribution=)]
    2019-02-17 lixon1988

    向各位专家学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1921238, encodeId=5a1419212386e, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Thu Nov 14 16:54:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582032, encodeId=f789158203275, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Mon Feb 18 13:54:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623030, encodeId=befe1623030ca, content=<a href='/topic/show?id=54a7358e4cb' target=_blank style='color:#2F92EE;'>#华人学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35874, encryptionId=54a7358e4cb, topicName=华人学者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1720449156, createdName=zhangxingru, createdTime=Mon Feb 18 13:54:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360853, encodeId=272e360853f0, content=真棒,继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sun Feb 17 12:53:44 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360845, encodeId=c64f3608454f, content=向各位专家学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtpPKU0wCQJX0qlicBd0iaQKZSwfxZJgU3Ep22UHmz5TRb7GYJePEmLTeibImwstiaEU5lqUQNCicibGkn/0, createdBy=bdcb1652180, createdName=lixon1988, createdTime=Sun Feb 17 11:18:36 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360829, encodeId=daef36082944, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Sun Feb 17 09:12:23 CST 2019, time=2019-02-17, status=1, ipAttribution=)]
    2019-02-17 王秀

    学习了,涨知识了!

    0

相关资讯

世界无烟日:香烟与风湿病之间不得不说的那些事

诚然,香烟是心血管疾病及多种癌症的罪魁祸首,同时,它也可以增加风湿病的疾病活动风险,加重风湿病患者的病情。

Semin Arthritis Rheu:甲氨喋呤治疗引起结核菌素试验的阳性率高:假阳性结果?

使用甲氨蝶呤与TST阳性的风险显著升高2倍相关,研究发现使用甲氨蝶呤与IGRA试验阳性之间没有统计学显著相关性。

Semin Arthritis Rheu:风湿病的姑息治疗和临终关怀

大多数患者被疼痛(81.4%)、厌食症(80.1%)和呼吸困难(77%)折磨。

风湿病患者该如何应对合并乙肝病毒感染?

在我国人群中乙肝表面抗原(HBsAg)携带者接近10%,风湿免疫性病由于自身免疫异常,需要行糖皮质激素、免疫抑制剂、生物制剂等治疗,用药后可造成细胞免疫低下,如果没有有效预防和干预,则可能出现乙肝病毒(HBV)再激活(复燃),表现为HBV大量复制,血清HBV DNA载量急剧升高,导致肝功能损伤,部分患者出现肝衰竭,甚至死亡。

风湿病患者原始细胞比例增高 不一定是白血病!

42岁女患者,确诊类风湿性关节炎15年,无正规治疗,一周余前关节疼痛加剧就诊,予甲氨蝶呤+雷公藤,口服一周,自觉症状缓解不明显,关节痛加剧,入院。第一次骨髓检查一类原始细胞比例偏高。治疗10天后进行二次骨穿骨髓检查:骨髓增生极度活跃,有核细胞量明显增多,中、晚幼及杆状核粒细胞增生为主。该风湿病患者又患白血病还是另有原因?

PLos One:使用风湿病专业引导员了解并减少药物依从性障碍

引导员发现并解决了许多与药物依从性相关的问题,患者对其所提供的服务感到满意。